Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Dec 19 - A U.S. appeals court on Thursday upheld a $95.2 million jury verdict for tobacco giant Altria (MO.N) in a patent dispute with rival R.J. Reynolds over e-cigarette technology. The U.S. Court
Dec 18 - Amgen's (AMGN.O) leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict made public on Wednesday, awarding Lindis $50.3 million ...
Both the local and central divisions in Milan have rejected Insulet's PI applications due to doubts about the validity of the patent-in-suit. This is a setback in the company's fight over insulin
Dec 23 - Netflix (NFLX.O) sued Broadcom (AVGO.O) in California federal court on Monday, accusing the chipmaker's cloud computing subsidiary VMware of violating its patent rights in "virtual machines
inventions to test drugs during the U.S. Food and Drug Administration application process. The companies stipulated last year that Regeneron was liable for patent infringement if the "safe harbor
April, the court’s 4a Civil Chamber ruled that Canfield’s device infringes QuantifiCare’s patent. The court under presiding judge Tilmann ordered the German and US subsidiaries of Canfield to cease
market exclusivity expired at the end of May 2017. Numerous companies applied for marketing authorisations in Germany, including Glenmark. Success in PI Although Mundipharma’s key patent EP 1 492 505
In the ongoing dispute over its highly successful weight-loss drug semaglutide, Novo Nordisk has suffered a further setback as the EPO revoked yet another patent from several under attack. After the
MU Ionics and CATL have resolved their patent disputes. They recently signed a licence deal that also impacts Opel, which uses the Chinese battery manufacturer's products in its electric vehicles and
light of day. Plaintiff MED-EL and its opponent Advanced Bionics have reached a settlement to end all ongoing disputes over cochlear implants. MED-EL has confirmed this to JUVE Patent. The opponents were
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
